Skip to main content
Premium Trial:

Request an Annual Quote

Transgenomic Licenses IntegraGen's Autism IP

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Transgenomic said today that it has licensed intellectual property from IntegraGen that it plans to use to develop a genetic test for autism risk in children who have older siblings who have already been diagnosed with an autism spectrum disorder.

Omaha, Neb.-based Transgenomic said that it will develop the test internally and expects it to be ready for launch by its CLIA-certified lab in the second quarter of 2010.

"We believe that the use of this test in conjunction with standard diagnostic tools will allow for the earlier diagnosis of autism, and importantly, the more timely initiation of treatment plans for these children," Transgenomic CEO and President Craig Tuttle said in a statement.

In addition to discovering genes and genetic variations for use in molecular diagnostic tests, Evry, France-based IntegraGen offers genotyping services to the research community.

Financial terms of the agreement were not released.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.